Huang, H., Mu, Y., Huang, Y., Ji, B., Wang, Y., Chen, C., Chen, Y., Luo, Z., Li, S., Zhang, Z., Wang, L., Conway, J. F., Yang, D., Wang, J., Sun, J., Li, S. (2025). Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance. Nature Communications. https://doi.org/10.1038/s41467-025-59490-y